Bios Partners
Overview
Bios Partners is a venture capital firm focused on identifying and investing in advanced biotech opportunities in overlooked and under-invested markets across the U.S. The firm aims to disrupt geographic favoritism in venture capital by supporting compelling scientific ventures in the Central U.S. that are often undervalued. Bios Partners is driven by a mission to cultivate these companies and bring innovative biotech solutions to market.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| i-Lumen Scientific | Sep 2025 | Series B | Lead |
| Bobcat Bio | Feb 2025 | Series A Extension | Co-investor |
| BobcatBio | Jul 2021 | Series A | Co-investor |
| Immusoft | Jan 2019 | Series B | Co-investor |
| Renibus Therapeutics | Sep 2023 | Series B | Lead |
For institutional investors. Book with your work email.
Key People
Aaron Fletcher
Founder & General Partner
Stella Robertson
Co-Founder, Partner
Amanda de la Garza
Partner
John Fucci
Partner
Timothy Van Treuren
Principal of New Investments
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bios Partners based?
Bios Partners is headquartered in Fort Worth, Texas, United States.
When was Bios Partners founded?
Bios Partners was founded in 2014.
How many portfolio companies does Bios Partners have?
Bios Partners has 9 portfolio companies in Caplight's dataset.
What are some companies in Bios Partners's portfolio?
Portfolio companies visible on Caplight include i-Lumen Scientific, Bobcat Bio, BobcatBio, Immusoft, Renibus Therapeutics.
What was Bios Partners's most recent investment shown here?
Bios Partners's most recent investment in this portfolio sample was in i-Lumen Scientific in 2025.
What sectors does Bios Partners focus on?
Bios Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Bios Partners focus on?
Bios Partners typically invests at the Mid stage.
What is Bios Partners's AUM?
Bios Partners's assets under management are estimated between $100.0M and $250.0M.